Effect of coenzyme Q10 versus placebo on improving symptoms of autism spectrum disorder

Effect of coenzyme Q10 versus placebo on improving symptoms of autism spectrum disorder: a double-blind randomized clinical trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120215009014N330

Enrollment

Registered

2020-01-06

Start date

2020-01-21

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism spectrum disorder. Autistic disorder

Interventions

Intervention 1: Intervention group: Coenzyme Q10 capsule 100 mg (manufactured by Hakiman Teb Pharmaceutical Company) once daily for 8 weeks. Intervention 2: Control group: Placebo capsule (manufacture

Eligibility

Sex/Gender

All

Age

6 Years to 12 Years

Inclusion criteria

Inclusion criteria: Age of 6 to 12 years, Autism spectrum disorder

Exclusion criteria

Exclusion criteria: Taking antioxidant and anti-inflammatory drugs over the past month, Drug intolerance

Design outcomes

Primary

Measure	Time frame
Symptoms of autism. Timepoint: Before the intervention and 8 weeks after that. Method of measurement: By using the standard questionnaire of Childhood Autism Rating Scale (CARS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Valentina Nematian

Hamedan University of Medical Sciences

valentinanematian@gmail.com+98 81 3838 0572

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026